Reuters logo
BRIEF-Nuvo Pharmaceuticals enters into license agreement with Sayre Therapeutics
March 28, 2017 / 12:02 PM / 8 months ago

BRIEF-Nuvo Pharmaceuticals enters into license agreement with Sayre Therapeutics

March 28 (Reuters) - Nuvo Pharmaceuticals Inc:

* Nuvo Pharmaceuticals™ enters into pennsaid® 2 pct license agreement with Sayre Therapeutics Pvt Ltd. For India, Sri Lanka, Bangladesh and Nepal

* Nuvo Pharmaceuticals Inc - has received an upfront payment and is eligible to receive milestone payments and a double-digit royalty on net sales

* Says Nuvo will supply pennsaid 2 pct to sayre on an exclusive basis from its manufacturing facility in varennes, québec

* Nuvo Pharmaceuticals Inc - agreement to distribute, market and sell pennsaid 2 pct in India, Sri Lanka, Bangladesh and Nepal ( territory)

* Nuvo Pharmaceuticals Inc - expect to complete pennsaid 2 pct out-licensing agreements for other territories throughout 2017 and 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below